Turning breakthrough science into financeable assets.
BioVergence builds scientific capital markets for life-science innovation - structuring digital securities and asset-level financing pathways around IP, data, milestones, royalties, and development programs.
Gain exposure to breakthrough innovations across biotech, AI and climate tech by contributing to and engaging with our recombinant asset library.
Build, remix, and commercialize—without the institutional red tape— through our community-powered bioconvergence hive.
Modular by Design
Science as Infrastructure
Incentive Drives Impact
A flourishing universe build on partnerships
We’re reimagining how science moves from lab to world.
BioVergence builds scientific capital markets for breakthrough science — structuring digital securities and financeable asset pathways around IP, data, milestones, royalties, and development programs
The BioVergence operating loop
Guardrails
We evaluate assets, identify proof points, design compliant financing structures, manage reporting and servicing, and use each diligence interaction to improve future underwriting.
Milestone verification, audit trail, disclosures, and separation of underwriting and marketing.
We combine asset-level financing, AI-driven diligence, and communities of action to help deep-science innovators access capital and build faster.
A living pipeline of innovation
From biofabrication to quantum therapeutics, BioVergence is building a pipeline of projects at the edge of deep tech and science. Every project is designed to scale, recombine, and evolve through the BioVergence ecosystem.
.svg)
A community platform driving insights
Become a part of the BioVergence ecosystem—a global network of scientists, builders, and backers collaborating across domains to launch modular innovation.
Our Team
Our team blends expertise across deep-tech, pharmaceuticals, genomics, and more. We are united by the belief that science should open, decentralized, and recombinable.